Interestingly, and in agreement with the effects of HMT on PP2A methylation and activity (Fig. 1E), this treatment clearly reduced nuclear accumulation of MITF and TFE3 in pancreatic cancer cells (Fig. 2D, E). The gene discussed is MITF; the disease is pancreatic neoplasm.